➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Johnson and Johnson
Moodys
AstraZeneca
Colorcon

Last Updated: May 13, 2021

DrugPatentWatch Database Preview

List of Excipients in Branded Drug XEGLYZE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Company Tradename Ingredient NDC Excipient Potential Generic Entry
Dr. Reddy’s Laboratories, Inc. XEGLYZE abametapir 43598-921 BENZYL ALCOHOL 2034-12-17
Dr. Reddy’s Laboratories, Inc. XEGLYZE abametapir 43598-921 BUTYLATED HYDROXYTOLUENE 2034-12-17
Dr. Reddy’s Laboratories, Inc. XEGLYZE abametapir 43598-921 CARBOMER 980 2034-12-17
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Johnson and Johnson
Express Scripts
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.